Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)

Clinical trial NCT07735130 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07735130
Sponsor: Seoul National University Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Transcatheter Aortic Valve Replacement (TAVR)Left Ventricular Hypertrophy Severe Aortic Stenosis

Start date: 2026-08-15
Primary completion: 2030-06-15
Enrollment: 632

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.